Skip to main content
. 2022 Sep;12(9):4474–4487. doi: 10.21037/qims-22-189

Table 3. Comparison of different parameters among different groups.

Parameters PD-L1 negative PD-L1 positive t/z value P value
ADC (×10−3 mm2/s) 1.32±0.31 1.34±0.22 −0.203 0.840a
D (×10−3 mm2/s) 1.18±0.22 1.03±0.09 3.921 <0.001a#
D* (×10−3 mm2/s) 26.82 (8.52, 55.91) 30.41 (15.52, 61.49) −0.629 0.529b
f (%) 33.27 (23.12, 42.67) 24.11 (15.09, 33.98) −2.497 0.013b#
MTRasym (3.5 ppm) (%) 2.08 (1.01, 2.95) 3.03 (2.00, 5.03) −3.308 0.001b#
SUVmax (g/cm3) 5.49 (3.79, 9.73) 11.64 (7.56, 17.98) −4.505 <0.001b#
MTV (cm3) 4.98 (1.90, 13.53) 18.02 (5.89, 34.31) −3.610 <0.001b#
TLG (g) 11.74 (4.47, 59.87) 83.42 (40.81, 195.27) −4.328 <0.001b#

Data are presented as mean ± SD or median (interquartile range). a, independent t-test; b, Mann-Whitney U test. #, indicates the comparison with statistical significance. PD-L1, programmed cell death-ligand 1; ADC, apparent diffusion coefficient; D, diffusion coefficient; D*, pseudo diffusion coefficient; f, perfusion fraction; MTRasym (3.5 ppm), magnetization transfer ratio asymmetry at 3.5 ppm; SUVmax, maximum standardized uptake value; MTV, metabolic tumor volume; TLG, total lesion glycolysis.